PAVmed Issuance Of Capital Stock from 2010 to 2024

PAVMZ Stock  USD 0.01  0.00  0.00%   
PAVmed Series Issuance Of Capital Stock yearly trend continues to be fairly stable with very little volatility. Issuance Of Capital Stock is likely to outpace its year average in 2024. During the period from 2010 to 2024, PAVmed Series Issuance Of Capital Stock regression line of annual values had r-squared of  0.15 and arithmetic mean of  15,013,180. View All Fundamentals
 
Issuance Of Capital Stock  
First Reported
2010-12-31
Previous Quarter
15.6 M
Current Value
29.4 M
Quarterly Volatility
29.1 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check PAVmed Series financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among PAVmed Series' main balance sheet or income statement drivers, such as Interest Expense of 559.5 K, Selling General Administrative of 32.5 M or Other Operating Expenses of 74.8 M, as well as many indicators such as Price To Sales Ratio of 11.54, Dividend Yield of 3.0E-4 or Days Sales Outstanding of 14.05. PAVmed financial statements analysis is a perfect complement when working with PAVmed Series Valuation or Volatility modules.
  
Check out the analysis of PAVmed Series Correlation against competitors.

Latest PAVmed Series' Issuance Of Capital Stock Growth Pattern

Below is the plot of the Issuance Of Capital Stock of PAVmed Series Z over the last few years. It is PAVmed Series' Issuance Of Capital Stock historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in PAVmed Series' overall financial position and show how it may be relating to other accounts over time.
Issuance Of Capital Stock10 Years Trend
Slightly volatile
   Issuance Of Capital Stock   
       Timeline  

PAVmed Issuance Of Capital Stock Regression Statistics

Arithmetic Mean15,013,180
Geometric Mean7,085,157
Coefficient Of Variation194.09
Mean Deviation15,735,217
Median4,410,824
Standard Deviation29,139,081
Sample Variance849.1T
Range115.1M
R-Value0.39
Mean Square Error773.1T
R-Squared0.15
Significance0.15
Slope2,561,173
Total Sum of Squares11887.2T

PAVmed Issuance Of Capital Stock History

202429.4 M
202315.6 M
20221.9 M
2021117 M
202016 M
20195.5 M

About PAVmed Series Financial Statements

PAVmed Series investors use historical fundamental indicators, such as PAVmed Series' Issuance Of Capital Stock, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in PAVmed Series. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Issuance Of Capital Stock15.6 M29.4 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for PAVmed Stock Analysis

When running PAVmed Series' price analysis, check to measure PAVmed Series' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PAVmed Series is operating at the current time. Most of PAVmed Series' value examination focuses on studying past and present price action to predict the probability of PAVmed Series' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PAVmed Series' price. Additionally, you may evaluate how the addition of PAVmed Series to your portfolios can decrease your overall portfolio volatility.